lubiprostone
Generic: lubiprostone
Labeler: zydus pharmaceuticals usa inc.Drug Facts
Product Profile
Brand Name
lubiprostone
Generic Name
lubiprostone
Labeler
zydus pharmaceuticals usa inc.
Dosage Form
CAPSULE
Routes
Active Ingredients
lubiprostone 8 ug/1
Manufacturer
Identifiers & Regulatory
Product NDC
70710-1641
Product ID
70710-1641_f06e99fa-9894-48ab-99d8-914987dbb73f
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA214131
Listing Expiration
2026-12-31
Marketing Start
2023-03-23
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
707101641
Hyphenated Format
70710-1641
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
lubiprostone (source: ndc)
Generic Name
lubiprostone (source: ndc)
Application Number
ANDA214131 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 8 ug/1
Packaging
- 100 CAPSULE in 1 BOTTLE (70710-1641-1)
- 60 CAPSULE in 1 BOTTLE (70710-1641-6)
Packages (2)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "f06e99fa-9894-48ab-99d8-914987dbb73f", "openfda": {"nui": ["N0000175573", "N0000175456"], "unii": ["7662KG2R6K"], "rxcui": ["616578", "794639"], "spl_set_id": ["6c11a204-6831-4269-a3c4-1702ed83f74b"], "pharm_class_epc": ["Chloride Channel Activator [EPC]"], "pharm_class_moa": ["Chloride Channel Activators [MoA]"], "manufacturer_name": ["Zydus Pharmaceuticals USA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (70710-1641-1)", "package_ndc": "70710-1641-1", "marketing_start_date": "20230323"}, {"sample": false, "description": "60 CAPSULE in 1 BOTTLE (70710-1641-6)", "package_ndc": "70710-1641-6", "marketing_start_date": "20230323"}], "brand_name": "Lubiprostone", "product_id": "70710-1641_f06e99fa-9894-48ab-99d8-914987dbb73f", "dosage_form": "CAPSULE", "pharm_class": ["Chloride Channel Activator [EPC]", "Chloride Channel Activators [MoA]"], "product_ndc": "70710-1641", "generic_name": "Lubiprostone", "labeler_name": "Zydus Pharmaceuticals USA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lubiprostone", "active_ingredients": [{"name": "LUBIPROSTONE", "strength": "8 ug/1"}], "application_number": "ANDA214131", "marketing_category": "ANDA", "marketing_start_date": "20230323", "listing_expiration_date": "20261231"}